ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1968 • 2014 ACR/ARHP Annual Meeting

    Highly activated IL-23/Th17 axis and JAK2/STAT3 signal pathway in PBMC of active AS patients involve in pathogenesis of AS

    Hongxiao Liu1, Peng Chen2, Yingyan Zhou2, Junyao Song2, Benyong Liu2, Xiaoyan Feng2 and Xinghua Feng2, 1Department of Rheumatology, Guang�'anmen Hospital, China Academy of Chinese Medical Sciences, Bei Jing, China, 2Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Bei Jing, China

    Background/Purpose: T helper cell(Th17), the third lineage of CD4+T cells, has been determined its important role in pathogenesis of AS, and its main effector, IL-17,…
  • Abstract Number: 1982 • 2014 ACR/ARHP Annual Meeting

    Final Year Medical Students Prefer E-Reading Content to Interactive Case-Based Quizzes in a Pediatric Rheumatology E-Learning Module

    Taunton R. Southwood, Institute of Child Health, University of Birmingham and Birmingham Children's Hospital, Birmingham, United Kingdom

    Background/Purpose:  Traditional medical student learning and teaching methods, such as lectures and bedside teaching, maybe inadequate for providing core knowledge and clinical skills in rheumatology,…
  • Abstract Number: 1978 • 2014 ACR/ARHP Annual Meeting

    Role of Monocytes Subsets in the Pathology of Rheumatoid Arthritis: Involvement in Endothelial Dysfunction and Proinflammatory Profile

    Chary Lopez-Pedrera, Patricia Ruiz-Limon, Carlos Perez-Sanchez, Rosario Carretero, Yolanda Jiménez Gómez, Ángeles Aguirre Zamorano, Jerusalem calvo-Gutierrez, Eduardo Collantes-Estevez, Alejandro Escudero-Contreras and Nuria Barbarroja, Rheumatology Unit, IMIBIC-Reina Sofia University Hospital, Cordoba, Spain

    Background/Purpose Different frequency of monocytes subsets has been reported in rheumatoid arthritis (RA).Human monocytes are divided into three main subpopulations according to expression of the…
  • Abstract Number: 1951 • 2014 ACR/ARHP Annual Meeting

    A Novel CD27(-) Spleen Tyrosine Kinase (Syk) Bright Memory B-Cell Subset Is Expanded in SLE

    Sarah Fleischer1, Claudia Giesecke1, Henrik Mei1, Peter E. Lipsky2, Capucine Daridon3 and Thomas Dörner3, 1Charité University Medicine Berlin, CC12, Dept. Medicine/Rheumatology and Clinical Immunology and German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany, Berlin, Germany, 2Peking Union Medical College Hospital, Beijing, China, 3CC12, Dept. Medicine/Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease known to be associated with a breakdown of self-tolerance, B-cell hyperactivity and disturbed B-cell homeostasis of…
  • Abstract Number: 1950 • 2014 ACR/ARHP Annual Meeting

    Circulating CD19+CD38+CD43+  B Cell Subset in SLE Patients Have More Cell Cycle Related Genes Than Healthy Controls

    Hiroshi Fujii1, Tomoaki Machiyama1, Kanae Akita2, Yukiko Kamogawa1, Ryu Watanabe1, Yoko Fujita3, Yuko Shirota4, Shinichiro Saito5, Tomonori Ishii6 and Hideo Harigae1, 1Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan, 2Department of Heatology and Rheumatology, Tohoku University, Sendai, Japan, 3Department of Hematolgy and rheumatolgy, Tohoku University, Sendai, Japan, 4Department of Hematology and Rheumatolgy, Tohoku University, Sendai, Japan, 5Department of hematology and rheumatology, Tohoku University, Sendai, Japan, 6Seiryouchou Aobaku, Tohoku University, Sendai, Japan

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic inflammatory disease associated with deposition of autoantibodies such as anti DNA antibody. After activation of B cells…
  • Abstract Number: 1949 • 2014 ACR/ARHP Annual Meeting

    Defective PTEN Regulation and Function Contributes to B Cell Hyper-Responsiveness in Systemic Lupus Erythematosus

    Xiangni Wu1, Yanxia Ye2, Jingwen Niu1, Yang Li1, Xin Li1, Xin You3, Hua Chen1, Lidan Zhao1, Xiaofeng Zeng4, Fengchun Zhang1, Fulin Tang1, Wei He1, Xuetao Cao5, Xuan Zhang6 and Peter E. Lipsky7, 1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Rheumatology & Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 3Division of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 4Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 5School of Basic Medicine, Peking Union Medical College, and Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China, 6Department of Rheumatology & Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 7NIH, Charlottesville, VA

    Background/Purpose: PTEN regulates normal signaling through the B cell receptor (BCR). In systemic lupus erythematosus(SLE), enhanced BCR signaling contributes to increased B cell activity. We, therefore,…
  • Abstract Number: 1948 • 2014 ACR/ARHP Annual Meeting

    A Dual Role for IFN-γ in Development of Peripheral B Cells in Lupus-Prone MRL/Lpr Mice

    Takeshi Machida1, Natsumi Sakamoto1, Gary S. Gilkeson2 and Hideharu Sekine1, 1Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan, 2Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: It had been reported previously that IFN-gamma and IFN-gamma-receptor-1 (IFNGR1) were required for auto-Ab production and development of renal disease in lupus-prone MRL/lpr mice.…
  • Abstract Number: 1967 • 2014 ACR/ARHP Annual Meeting

    Transforming Growth Factor Beta Is a Major Regulator of Micro-RNA Synthesis in Rheumatoid Arthritis Synovial Fibroblasts

    Anna Engler1, Emmanuel Karouzakis1, Christoph Kolling2, Renate E. Gay3, Steffen Gay1 and Caroline Ospelt1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Schulthess Clinic, Zurich, Switzerland, 3Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland

    Background/Purpose Transforming growth factor beta (TGFβ) modulates microRNA (miRNA) biogenesis in a variety of cell types. The expression of miRNAs is deregulated in the synovial…
  • Abstract Number: 1966 • 2014 ACR/ARHP Annual Meeting

    CTLA4-Ig (abatacept) Modulate in Vitro the ICAM1 and VEGFR-2 Expression in Human Endothelial Cells

    Maurizio Cutolo1, Paola Montagna2, Stefano Soldano2, Paola Contini3, Barbara Villaggio4, Alberto Sulli1, Sabrina Paolino1, Carmen Pizzorni1, Bruno Seriolo1, Giuseppe Zampogna2, Marco A. Cimmino1 and Renata Brizzolara2, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, 2Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy, 3Division of Clinical Immunology, Department of Internal Medicine, University of Genova, Genova, Italy, 4Research Laboratory of Nephrology, Department of Internal Medicine, University of Genova, Genova, Italy

    Background/Purpose CTLA4-Ig (abatacept) is employed as biological agent in rheumatoid arthtritis (RA) treatment and interacts with the costimulatory molecule CD86 expressed by different cells involved…
  • Abstract Number: 1965 • 2014 ACR/ARHP Annual Meeting

    Characterization of the Thyroid Hormone System in Rheumatoid Arthritis

    Anna-Sophia Pörings1, Torsten Lowin2, Luise Rauch1, Tanja Späth1, Angelika Graeber2 and Rainer Straub3, 1Department of Internal Medicine I, Laboratory of Exp. Rheumatology and Neuroendocrino-Immunology, Regensburg, Germany, 2Department of Internal Medicine I, Laboratory of Exp. Rheumatology and Neuroendocrino-Immunology, University Hospital of Regensburg, Regensburg, Germany, 3Internal Medicine, University Hospital Regensburg, Regensburg, Germany

    Background/Purpose: Chronic inflammation is characterized by an energy appeal reaction supporting high energy demand of the activated immune system. Thyroid hormones are strongly associated with…
  • Abstract Number: 1964 • 2014 ACR/ARHP Annual Meeting

    Changes in Soluble CD18 Reflect Latency in the Immune System and Predict Radiographic Progression in Early Rheumatoid Arthritis

    Tue Wenzel Kragstrup1, Babak Jalilian1, Kresten Krarup Keller2, Kristian Stengaard-Pedersen3, Merete Lund Hetland4, Kim Hørslev-Petersen5, Peter Junker6, Mikkel Østergaard4, Ellen Margrethe Hauge7,8, Malene Hvid1, Thomas Vorup-Jensen1 and Bent Deleuran1,3, 1Department of Biomedicine, Aarhus University, Aarhus, Denmark, 2Aarhus University Hospital, Aarhus, Denmark, 3Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 4Glostrup University Hospital, Glostrup, Denmark, 5Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Denmark, 6Odense University Hospital, Odense, Denmark, 7Dept. of Anatomi, Aarhus University, Aarhus, Denmark, 8Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose In early rheumatoid arthritis (RA), clinical disease characterized by swollen and painful joints is caused by synovitis. However, presence of autoantibodies may precede the…
  • Abstract Number: 1963 • 2014 ACR/ARHP Annual Meeting

    Hierarchical Role of PI3K/Akt/mTOR Signaling Cascade on: Tissue Inflammation, Organization and Angiogenesis in Autoimmune Arthritis

    Siba Raychaudhuri1, Anupam Mitra2, Ananya Datta Mitra3, Christine Abria4 and Smriti K. Raychaudhuri3, 1Med/Rheumatology, Univ California Davis/VA Sac, Davis, CA, 2Dermatology, VA Sacramento Medical Center, Mather, CA, 3Rheumatology, VA Sacramento Medical Center, Mather, CA, 4Research, VA Sacramento Medical Center, Mather, CA

    Background/Purpose: The PI3K/Akt/mTOR signaling proteins are pro-growth/pro-survival and thus likely to regulate inflammatory cascades in autoimmune diseases (1).  The key pathologic outcome in psoriatic arthritis…
  • Abstract Number: 1962 • 2014 ACR/ARHP Annual Meeting

    Inflammatory Properties of Inhibitor of DNA Binding 1 As a Unique Fibroblast Derived Nuclear Protein

    Gautam Edhayan1, Christine M. Ha1, Ray A. Ohara1, Takeo Isozaki1, M. Asif Amin1, Ali Arbab2, Pei-Suen Tsou3, Phillip L. Campbell4, Elena Schiopu3, Dinesh Khanna3, Rachel Morgan1, Sean C. Friday1, David A. Fox1 and Jeffrey Ruth1, 1Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 2Georgia Regents University, Augusta, GA, 3University of Michigan Scleroderma Program, Ann Arbor, MI, 4Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

    Background/Purpose: Inhibitor of DNA binding 1 (Id1) is a nuclear protein containing a basic helix-loop-helix (bHLH) domain that regulates cell growth by selective binding and…
  • Abstract Number: 1961 • 2014 ACR/ARHP Annual Meeting

    Chemokine-like Receptor 1 (CMKLR1) is Expressed on Synoviocytes and Proinflammatory Monocytes in Arthritis and is Predominantly Regulated By β arrestin 2 and G Protein Coupled Receptor Kinase (GRK) 6

    D. Stephen Serafin1, Maria F. Sassano2, Daniel Mattox1, Roman Timoshchenko1, Matthew J. Billard1, David P. Siderovski3, Bryan Roth4 and Teresa K. Tarrant5, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Pharmacology, Dept. of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, 4Dept. of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 5Medicine/Rheumatology, Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose Chemokine-like receptor 1 (CMKLR1) is a G protein-coupled receptor (GPCR) expressed by inflammatory monocytes and up-regulated in fibroblast-like synoviocytes (FLSs), both of which are…
  • Abstract Number: 1960 • 2014 ACR/ARHP Annual Meeting

    NF-κB-Inducing Kinase (NIK) Is Expressed in Synovial Endothelial Cells in Early Arthritis Patients and Correlates with Local Disease Activity and Systemic Markers of Inflammation

    Karen I. Maijer1, Ae-Ri Noort2, Maria J. H. de Hair1, Christiaan van der Leij3, Katinka P.M. van Zoest4, Danielle M. Gerlag5,6, Mario Maas3, Paul-Peter Tak1,7,8 and Sander W. Tas2, 1Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Department of Clinical Immunology & Rheumatology and Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Department of Radiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 4Department of Clinical Immunology & Rheumatology and Laboratory for Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 5Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 6GlaxoSmithKline, Cambridge, United Kingdom, 7University of Cambridge, Cambridge, United Kingdom, 8GlaxoSmithKline, Stevenage, United Kingdom

    Background/Purpose The NF-κB family of transcription factors is strongly involved in synovial inflammation. We have previously shown that NF-κB-inducing kinase (NIK) is a key regulator…
  • « Previous Page
  • 1
  • …
  • 1919
  • 1920
  • 1921
  • 1922
  • 1923
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology